Calpurbatug

DB18734InvestigationalProtein Based Therapies

Calpurbatug (TRL1068) is a high-affinity and broad-spectrum human antibody that targets and disintegrates bacterial biofilm.

Code names
TRL-1068

Resolves to

Compound
UNIIF4M5MQK5W7CAS2635404-72-5

What you can answer from here — as of April 23, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Calpurbatug, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In